Skip to main content
Log in

Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Nutritional factors is one of the most important regulators in the progression of cancer. Some dietary elements promote the growth of cancer but others, such as plant-derived compounds, may reverse this process.

Purpose

We tried to investigate yet another approach of cancer prevention through cancer cell differentiation, using a common non-mutagenic flavonoid apigenin 7-glucoside.

Methods

HL-60 cells were treated with or without apigenin 7-glucoside. Cell proliferation was measured by MTT assay, and the cell cycle distribution was estimated by propidium iodide staining of DNA. To determine cellular differentiation, cell surface differentiation markers CD11b and CD14 were used. Two-dimensional gel electrophoresis was then performed to identify proteins that may be important in HL-60 cell differentiation following apigenin 7-glucoside treatment.

Results

Apigenin 7-glucoside inhibited HL-60 cell growth, dose- and time-dependently, but did not cause apoptosis. The distribution of cells at different stages in the cell cycle indicated an accumulation of treated cells in G2/M phase. Moreover, apigenin 7-glucoside induced granulocytic differentiation of HL-60 cells. Ten proteins that might play essential role in granulocytic differentiation were identified by proteomics.

Conclusions

A complete understanding of the preventive effects of plant-based diet on cancer depends on the mechanisms of action of different plant components on processes. We hope these findings may contribute to the understandings of the different approaches for chemoprevention of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (2007) Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 99:1200–1209

    Article  Google Scholar 

  2. Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, Adams-Campbell LL, Rosenberg L (2010) Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am J Epidemiol 172:1268–1279

    Article  Google Scholar 

  3. Büchner FL, Bueno-de-Mesquita HB, Ros MM, Overvad K, Dahm CC, Hansen L et al (2010) Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 19:2278–2286

    Article  Google Scholar 

  4. Galeone C, Pelucchi C, Levi F, Negri E, Franceschi S, Talamini R, Giacosa A, La Vecchia C (2006) Onion and garlic use and human cancer. Am J Clin Nutr 84:1027–1032

    CAS  Google Scholar 

  5. Tsiftsoglou AS, Pappas IS, Vizirianakis IS (2003) Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther 100:257–290

    Article  CAS  Google Scholar 

  6. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB (2001) Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 90:105–156

    Article  CAS  Google Scholar 

  7. Visioli F, Borsani L, Galli C (2000) Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res 47:419–425

    Article  CAS  Google Scholar 

  8. Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30:233–245

    CAS  Google Scholar 

  9. Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H, Peppelenbosch MP (2010) Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death and Disease 1:1–12

    Article  Google Scholar 

  10. Vargo MA, Voss OH, Poustka F, Cardounel AJ, Grotewold E, Doseff AI (2006) Apigenin-induced-apoptosis is mediated by the activation of PKCδ and caspases in leukemia cells. Biochem Pharmacol 72:681–692

    Article  CAS  Google Scholar 

  11. Nowak D, Stewart D, Koeffler HP (2009) Differentiation therapy of leukemia: 3 decades of development. Blood 113:3655–3665

    Article  CAS  Google Scholar 

  12. Kim SH, Yoo JC, Kim TS (2009) Nargenicin enhances 1, 25-dihydroxyvitamin D3- and all-trans retinoic acid-induced leukemia cell differentiation via PKCβI/MAPK pathways. Biochem Pharmacol 77:1694–1701

    Article  CAS  Google Scholar 

  13. Tsolmon S, Kurita Y, Yamada P, Shigemori H, Isoda H (2009) Indoleacetic acid falcarindiol ester induces granulocytic differentiation of the human leukemia cell line HL-60. Planta Med 75:49–54

    Article  CAS  Google Scholar 

  14. Lee KW, Kim HJ, Lee YS, Park HJ, Choi JW, Ha J, Lee KT (2007) Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis 28:1928–1936

    Article  CAS  Google Scholar 

  15. Sánchez Y, Amrán D, de Blas E, Aller P (2009) Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) protein kinase modulation and reactive oxygen species generation. Biochem Pharmacol 77:384–396

    Article  Google Scholar 

  16. Choi EJ, Kim GH (2009) Apigenin causes G2/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem 20:285–290

    Article  CAS  Google Scholar 

  17. Bektic J, Guggenberger R, Spengler B, Christoffel V, Pelzer A, Berger AP, Ramoner R, Bartsch G, Klocker H (2006) The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S. Maturitas 55:S37–S46

    Article  CAS  Google Scholar 

  18. Wang IK, Lin-Shiau SY, Lin JK (1999) Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35:1517–1525

    Article  CAS  Google Scholar 

  19. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinogen 28:102–110

    Article  Google Scholar 

  20. Kawabe T (2004) G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 3:513–519

    CAS  Google Scholar 

  21. Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962–978

    Article  CAS  Google Scholar 

  22. Mansfield PJ, Suchard SJ (1993) Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil- like HL-60 cells. J Immunol 150:1959–1970

    CAS  Google Scholar 

  23. Tsolmon S, Nakazaki E, Han J, Isoda H (2011) Apigetrin induces erythroid differentiation of human leukemia cells K562: proteomics approach. Mol Nutr Food Res 55:S93–S102

    Article  CAS  Google Scholar 

  24. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP (2005) Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 69:1421–1432

    Article  CAS  Google Scholar 

  25. Németh K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA (2003) Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42:29–42

    Article  Google Scholar 

  26. Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13:572–584

    Article  CAS  Google Scholar 

  27. Gradolatto A, Canivenc-Lavier MC, Basly JP, Siess MH, Teyssier C (2004) Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. Drug Metab Dispos 32:58–65

    Article  CAS  Google Scholar 

  28. Gradolatto A, Basly JP, Berges R, Teyssier C, Chagnon MC, Siess MH, Canivenc-Lavier MC (2005) Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 33:49–54

    Article  CAS  Google Scholar 

  29. Chiang LC, Ng LT, Lin IC, Kuo PL, Lin CC (2006) Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett 237:207–214

    Article  CAS  Google Scholar 

  30. Gupta S, Afaq F, Mukhtar H (2001) Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 287:914–920

    Article  CAS  Google Scholar 

  31. Tzivion G, Avruch J (2002) 14–3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277:3061–3064

    Article  CAS  Google Scholar 

  32. Dalal SN, Yaffe MB, DeCaprio JA (2004) 14–3-3 family members act coordinately to regulate mitotic progression. Cell Cycle 3:672–677

    Article  CAS  Google Scholar 

  33. O’Connell MJ, Walworth NC, Carr AM (2000) The G2-phase DNA-damage checkpoint. Trends Cell Biol 10:296–303

    Article  Google Scholar 

  34. Wang Y, Jacobs C, Hook KE, Duan H, Booher RN, Sun Y (2000) Binding of 14–3-3β to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. Cell Growth Differ 11:211–219

    CAS  Google Scholar 

  35. Naryzhny SN (2008) Proliferating cell nuclear antigen: a proteomics view. Cell Mol Life Sci 65:3789–3808

    Article  CAS  Google Scholar 

  36. Witko-Sarsat V, Mocek J, Bouayad D, Tamassia N, Ribeil JA, Candalh C, Davezac N, Reuter N, Mouthon L, Hermine O, Pederzoli-Ribeil M, Cassatella MA (2010) Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J Exp Med 207:2631–2645

    Article  CAS  Google Scholar 

  37. Zeng XR, Hao H, Jiang Y, Lee MY (1994) Regulation of human DNA polymerase δ during the cell cycle. J Biol Chem 269:24027–24033

    CAS  Google Scholar 

  38. Kawabe T, Suganuma M, Ando T, Kimura M, Hori H, Okamoto T (2002) Cdc25C interacts with PCNA at G2/M transition. Oncogene 21:1717–1726

    Article  CAS  Google Scholar 

  39. Le Sourd F, Boulben S, Le Bouffant R, Cormier P, Morales J, Belle R, Mulner-Lorillon O (2006) eEF1B: at the dawn of the 21st century. Biochim Biophys Acta 1759:13–31

    Article  CAS  Google Scholar 

  40. Nicolas E, Ait-Si-Ali S, Trouche D (2001) The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein. Nucleic Acids Res 29:3131–3136

    Article  CAS  Google Scholar 

  41. Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Oikawa T (2003) Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 22:8688–8698

    Article  CAS  Google Scholar 

  42. Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG (2006) ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 107:3330–3338

    Article  CAS  Google Scholar 

  43. Munshi CB, Graeff R, Lee HC (2002) Evidence for a causal role of CD38 expression in granulocytic differentiation of human HL-60 cells. J Biol Chem 277:49453–49458

    Article  CAS  Google Scholar 

  44. Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476

    CAS  Google Scholar 

  45. Oshizawa T, Yamaguchi T, Suzuki K, Yamamoto Y, Hayakawa T (2003) Possible involvement of optimally phosphorylated L-plastin in activation of superoxide-generating NADPH oxidase. J Biochem 134:827–834

    Article  CAS  Google Scholar 

  46. El Btaouri H, Claisse D, Bellon G, Antonicelli F, Haye B (1996) In vivo modulation of annexins I, II and V expression by thyroxine and methylthiouracil. Eur J Biochem 242:506–511

    Article  CAS  Google Scholar 

  47. Karlsson J, Fu H, Boulay F, Dahlgren C, Hellstrand K, Movitz C (2005) Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J Leukoc Biol 78:762–771

    Article  CAS  Google Scholar 

  48. Kim KM, Kim DK, Park YM, Kim CK, Na DS (1994) Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 343:251–255

    Article  CAS  Google Scholar 

  49. Mira JP, Dubois T, Oudinet JP, Lukowski S, Russo-Marie F, Geny B (1997) Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. J Biol Chem 272:10474–10482

    Article  CAS  Google Scholar 

  50. Yan M, Di Ciano-Oliveira C, Grinstein S, Trimble WS (2007) Coronin function is required for chemotaxis and phagocytosis in human neutrophils. J Immunol 178:5769–5778

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the JST-JICA Science and Technology Research Partnership for Sustainable Development Program (SATREPS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroko Isoda.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 47 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakazaki, E., Tsolmon, S., Han, J. et al. Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells. Eur J Nutr 52, 25–35 (2013). https://doi.org/10.1007/s00394-011-0282-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-011-0282-4

Keywords

Navigation